The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
While cervical cancer is preventable in many cases, it continues to generate a significant burden of disease and death in low- and middle-income countries (LMICs). More than 300,000 women die of cervical cancer each year, with more than 90% of deaths occurring in LMICs. Malawi has the highest cervical cancer incidence and mortality in the world, with an age-standardized rate of 75.9 and 49.8 per 100,000 population respectively. Cervical cancer is also the most common female cancer among women aged 15 to 44 years accounting 45.4% of all cancers in women in the country.
High prevalence of HIV, human papilloma virus (HPV), inadequate screening and treatment services for precancerous lesions, late diagnosis, limited access to timely, standard treatment of cancer and palliative care are the main risk factors for high cervical cancer incidence and mortality. HPV vaccination and effective programs to screen and treat women for pre-cancerous lesions (primary and secondary prevention, respectively) offer the opportunity to eliminate cervical cancer as a public health problem.
This new program aims to reach women with effective secondary prevention services by leveraging existing platforms such as multiplex diagnostics and VIA screening programs to deploy innovative tools on the market that are not yet widely used in Malawi such as HPV tests for screening, and portable devices to treat pre-cancerous lesions.
CHAI is therefore seeking an experienced, highly motivated, flexible, and result oriented individual to support scale up of secondary prevention of cervical cancer through innovative screening and treatment approaches. The Associate will be based in Lilongwe, Malawi with up to 50-75% travel in-country, and will report to the Program Manager, SRMNH.